Cargando…

Delayed initiation of adjuvant chemotherapy in older women with breast cancer

BACKGROUND: Adjuvant chemotherapy benefits early‐stage breast cancer (BC) patients. Older women receive guideline‐adherent treatment less frequently and experience treatment delays more frequently. We evaluated factors associated with delaying adjuvant chemotherapy and the delays’ survival impact in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith‐Graziani, Demetria, Lei, Xiudong, Giordano, Sharon H., Zhao, Hui, Karuturi, Meghan, Chavez‐MacGregor, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541132/ https://www.ncbi.nlm.nih.gov/pubmed/32767723 http://dx.doi.org/10.1002/cam4.3363

Ejemplares similares

Movement Through Chemotherapy Delay to Initiation Among Breast Cancer Patients: A Qualitative Analysis
por: Housten, Ashley J, et al.
Publicado: (2022)

Patient‐reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment
por: Adesoye, Taiwo, et al.
Publicado: (2023)

Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2023)

Advice from One Patient to Another: Qualitative Analysis of Patients’ Perspectives About Chemotherapy Initiation
por: Malinowski, Catalina, et al.
Publicado: (2022)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US
por: Sosa, Alan, et al.
Publicado: (2022)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
por: Kolla, Bhaskar C., et al.
Publicado: (2020)

Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
por: Yu, Ke-Da, et al.
Publicado: (2016)

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer
por: Licata, Luca, et al.
Publicado: (2023)

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
por: Chang, Alex Yuang-Chi, et al.
Publicado: (2016)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
por: Chae, Young Kwang, et al.
Publicado: (2013)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple‐negative breast cancer
por: Heeg, Erik, et al.
Publicado: (2019)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
por: Zarcos‐Pedrinaci, Irene, et al.
Publicado: (2019)

Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstruction
por: Huttunen, Tuomas, et al.
Publicado: (2022)

The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
por: Simpson, G. S., et al.
Publicado: (2014)

Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism—A systematic review
por: Buch, Kristian, et al.
Publicado: (2018)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer
por: O’Neil, Daniel S, et al.
Publicado: (2023)

Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins
por: Bernard, Mark E., et al.
Publicado: (2018)

Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer
por: Layman, Rachel M., et al.
Publicado: (2022)

High level of unmet needs and anxiety are associated with delayed initiation of adjuvant chemotherapy for colorectal cancer patients
por: Zhu, Li, et al.
Publicado: (2020)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy
por: Bennedsgaard, Kristine, et al.
Publicado: (2020)

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study
por: Jongeneel, Gabrielle, et al.
Publicado: (2021)

Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis
por: Harling, Leanne, et al.
Publicado: (2020)

Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
por: Fernanda Amary, M, et al.
Publicado: (2014)

Impact of age on adjuvant chemotherapy after radical resection in patients with non–small cell lung cancer
por: Zhai, Xiaoyu, et al.
Publicado: (2016)

Association between weight gain during adjuvant chemotherapy for early‐stage breast cancer and survival outcomes
por: Schvartsman, Gustavo, et al.
Publicado: (2017)

Self‐evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study
por: Galizia, Danilo, et al.
Publicado: (2018)

Adjuvant chemotherapy versus chemoradiation in high‐risk pancreatic adenocarcinoma: A propensity score‐matched analysis
por: Raoof, Mustafa, et al.
Publicado: (2019)

The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC
por: Tasoulas, Jason, et al.
Publicado: (2021)

Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
por: Hingmire, Sachin S., et al.
Publicado: (2017)

Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study
por: Dumont, Frédéric, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p1d5jv4h75ukt8to1kc9ql69ce